USFDA APPLICATION NUMBER - 22023 / DOSAGE - POWDER;INTRAVENOUS - EQ 150MG BASE/VIAL
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
FOSAPREPITANT DIMEGLUMINE(UNII: D35FM8T64X) (APREPITANT - UNII:1NF15YR6UY) | APREPITANT | 150mg in 5 |
Inactive Ingredients
Ingredient Name | Athenex Pharmaceutical Division, LLC. | Lupin Pharmaceuticals, Inc. | Meitheal Pharmaceuticals Inc. | Merck Sharp & Dohme Corp. | Mylan Institutional LLC | SunGen Pharma, LLC |
---|---|---|---|---|---|---|
ANHYDROUS LACTOSE(3SY5LH9PMK) | ||||||
EDETATE DISODIUM(7FLD91C86K) | ||||||
HYDROCHLORIC ACID(QTT17582CB) | ||||||
polysorbate 80(6OZP39ZG8H) | ||||||
SODIUM HYDROXIDE(55X04QC32I) |
LOOKING FOR A SUPPLIER?